Trial reportBMC women's health2026
How painful is Implanon NXT
Trial report in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo determine and compare the pain relief between Acetaminophen, Mefenamic Acid and Diclofenac Sodium in participants who had just had Implanon NXT
methods129 healthy female participants were recruited from four clinics prior to Implanon NXT
resultsThe Sum of Pain Intensity Differences (SPID) for Diclofenac Sodium group is 1009 mm VAS, for Mefenamic Acid group is 446 mm VAS, for Acetaminophen group is 296 mm VAS, and for Control group is 58 mm VAS. Kruskal Wallis ANOVA indicated that there were statistically significant differences between the Pain Intensity Differences on Day 2 (PID2) assigned to the "Mefenamic Acid" group and "Control" group (p = 0.021, adjusted significance (Bonferroni's) p = 0.013). The ANCOVA indicated that, after accounting for the effects of different baseline pain intensities at the beginning of the study, there was a statistically significant effect of drugs used on Pain Intensity Difference Day 2 (PID2), p = 0.024, partial ƞ2 = 0.07. Post-hoc testing revealed that the participants in the Mefenamic Acid group reported higher Pain Intensity Difference on Day 2 (PID2) than the Control group.
conclusionAll oral analgesics demonstrated a reduction in pain score. Based on this limited study, the most suitable analgesic for pain management post Implanon NXT
trial registrationThis study was retrospectively registered with the Thai Clinical Trial Registry: TCTR20260331002 ( https://www.thaiclinicaltrials.org/show/TCTR20260331002) on 31st March 2026.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.